The impact of the Glasgow Prognostic Score on survival in second-line chemotherapy for metastatic colorectal cancer patients with BRAF V600E mutation

BACKGROUND: BRAF (v-raf murine sarcoma viral oncogene homolog B1) V600E mutant colorectal cancer is associated with short survival. Recently, clinical trials have been conducted to improve outcomes of second or later lines of chemotherapy. However, there is a paucity of reference data pertaining to...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Ther Adv Med Oncol
Main Authors: Mitani, Seiichiro, Taniguchi, Hiroya, Sugiyama, Keiji, Masuishi, Toshiki, Honda, Kazunori, Narita, Yukiya, Kadowaki, Shigenori, Ura, Takashi, Ando, Masashi, Tajika, Masahiro, Yatabe, Yasushi, Muro, Kei
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2019
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6348546/
https://ncbi.nlm.nih.gov/pubmed/30719102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835918820298
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki